Prognostic Biomarkers in Patients with Resected Cholangiocarcinoma: A Systematic Review and Meta-analysis
Prognostic Biomarkers in Patients with Resected Cholangiocarcinoma: A Systematic Review and Meta-analysis
A. T. Ruys,B. Groot Koerkamp,3 Authors,T. M. Gulik
2014 · DOI: 10.1245/s10434-013-3286-x
Annals of Surgical Oncology · 59 Citations
TLDR
Meta-analysis demonstrated that the biomarkers fascin, EGFR, M UC1, MUC4, and p27 are associated with survival in patients with resected CC and future studies should validate these, and other promising biomarkers, and adhere to the REMARK guidelines.